# Enhanced Natural Killer Cell Activity and RBAC

> **NCT02019628** · NA · COMPLETED · sponsor: **University of Miami** · enrollment: 20 (actual)

## Conditions studied

- Family Member

## Interventions

- **DIETARY_SUPPLEMENT:** Rice Bran Arabinoxylan Compound (RBAC)

## Key facts

- **NCT ID:** NCT02019628
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2011-04
- **Final completion:** 2011-11
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02019628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02019628, "Enhanced Natural Killer Cell Activity and RBAC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02019628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*